Financial insights of QXL

MyFinsight

Income Statement	2026-06-30
Revenues	293
Traffic-acquisition and related costs	134
Research and development	185
Selling and marketing	26
General and administrative	1,015
Depreciation and amortization	228
Other expenses, net	100
Operating loss	-1,395
Gain from deconsolidation of cliniquantum	3,831
Financial expenses, net	113
Income (loss) from continuing operations, before taxes	2,323
Tax benefit	-94
Net income (loss) from continuing operations	2,417
Net income (loss)	2,417
Less net loss attributable to non-controlling interests	-68
Net income (loss) attributable to shareholders of quantum x labs inc	2,485

Basic EPS	0.17
Diluted EPS	0.12
Basic Average Shares	14,292,085
Diluted Average Shares	20,074,625

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.